Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Tata Consultancy Services Ltd | 4 |
| 2 | Charité – Universitätsmedizin Berlin | 3 |
| 3 | Council of Scientific and Industrial Research | 2 |
| 4 | Inmed Pharmaceuticals Inc | 2 |
| 5 | Ministry of Science and Technology | 2 |
| 6 | Pendulum Therapeutics Inc | 2 |
| 7 | Weizmann Institute of Science | 2 |
| 8 | Beihang University | 1 |
| 9 | Braskem SA | 1 |
| 10 | Chinese Academy of Medical Sciences & Peking Union Medical College | 1 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C12N | Microorganisms, enzymes | 40 |
| 2 | C12P | Fermentation, enzyme processes | 36 |
| 3 | C12Y | Enzyme nomenclature (EC numbers) | 29 |
| 4 | C12R | 14 | |
| 5 | A61K | Medicinal preparations | 12 |
| 6 | Y02E | Climate change mitigation: energy | 10 |
| 7 | A61P | Therapeutic activity (drug indications) | 8 |
| 8 | C07D | Heterocyclic compounds | 7 |
| 9 | A23L | Foods and beverages (general) | 6 |
| 10 | A23K | Animal feeds | 5 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| METHOD AND SYSTEM FOR DESIGNING PERSONALIZED THERAPEUTICS AND DIET BASED ON FUNCTIONS OF MICROBIOME | 2022 | Tata Consultancy Services Ltd | 5 |
| Clostridium tyrobutyricum recombinant strain for producing butyl butyrate and construction method and application thereof | 2022 | 5 | |
| Methods and compositions for treating liver disorders | 2022 | Pendulum Therapeutics Inc | 3 |
| Branched chain fatty acids and their biological production | 2013 | Procter and Gamble Co | 7 |
| Network-based microbial compositions and methods | 2023 | Nestle SA | 1 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 4 |
| 2020 | 8 |
| 2021 | 5 |
| 2024 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Kevin A. Reynolds | Virginia Commonwealth University | 5 |
| 2 | Harry J. Flint | University of Aberdeen | 4 |
| 3 | Wolfgang Buckel | Philipps University of Marburg | 3 |
| 4 | Petra Louis | University of Aberdeen | 3 |
| 5 | Sandro Ghisla | University of Konstanz | 3 |
| 6 | Sang Yup Lee | Korea Advanced Institute of Science and Technology | 3 |
| 7 | Donald Becker | University of Minnesota | 2 |
| 8 | Peter F. Leadlay | University of Cambridge | 2 |
| 9 | Ruma Banerjee | University of Nebraska–Lincoln | 2 |
| 10 | Tom Van de Wiele | Ghent University | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers | 2011 | 1344 | Gut microbiota and health |
| Diversity of human colonic butyrate‐producing bacteria revealed by analysis of the butyryl‐CoA:acetate CoA‐transferase gene | 2009 | 798 | Genomics and Phylogenetic Studies |
| Butyrate-producingClostridiumcluster XIVa species specifically colonize mucins in anin vitrogut model | 2012 | 661 | Gut microbiota and health |
| Automated Design of Efficient and Functionally Diverse Enzyme Repertoires | 2018 | 312 | Genomics and Phylogenetic Studies |
| Reconstructing the clostridial n-butanol metabolic pathway in Lactobacillus brevis | 2010 | 169 | Biofuel production and bioconversion |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Butiryl-CoA?
Which organizations hold the most patents involving Butiryl-CoA?
What has been the recent patent filing trend for Butiryl-CoA?
Which researchers have published the most papers on Butiryl-CoA?
What are the primary patent technology classifications for Butiryl-CoA inventions?